Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
about
Severe hypophosphataemia after intravenous iron administrationCurrent misconceptions in diagnosis and management of iron deficiencyComparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.Letter: inconsistency in reporting of hypophosphatemia after intravenous iron.The safety of available treatment options for iron-deficiency anemia.Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice.Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report.Comparative safety of intravenous ferumoxytol vs ferric carboxymaltose in iron deficiency anemia: A randomized trial.Intravenous Irons: From Basic Science to Clinical Practice
P2860
Q37704389-D4743957-F5E5-4348-8830-CBDBDAC817E6Q41547046-74EDA7EC-6877-4646-BFF9-71B36AE5181DQ42370571-55424BC1-9ECC-458C-9436-204FD8BE808AQ47821861-673ECB14-D02B-46B4-868C-A302D8329911Q48225857-C7AD73DC-F732-4B3C-B045-A96AA67762AEQ48245674-92A140A5-D267-4FBA-A671-C88AB15933E2Q48548255-BB1CCBEB-076D-4489-B5A6-2E2B55E7C877Q49860906-F6293E42-78FE-4AA8-946D-A4F6608A3BD6Q50080883-0EBEE9DF-8378-4176-8EDD-5BFBC8C996BCQ50125158-9E33210D-E3DC-4629-AD01-F21F67288624Q57167424-822B9E90-C48C-4BB5-91C8-E215588F3713
P2860
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
@ast
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
@en
type
label
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
@ast
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
@en
prefLabel
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
@ast
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
@en
P2093
P2860
P1433
P1476
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
@en
P2093
Alexander Moschen
Andrea Griesmacher
André Viveiros
Armin Finkenstedt
Benedikt Schaefer
Heinz Zoller
Herbert Tilg
Irene Sulzbacher
Maria Effenberger
Philipp Würtinger
P2860
P304
P356
10.1371/JOURNAL.PONE.0167146
P407
P577
2016-12-01T00:00:00Z